Immunovant, Inc.

IMVT·NASDAQ·$33.83Share Price as of 11/2·$7BMarket Cap as of 11/2

Financials

10-QQ1 ended 06/30/2608/06/26 10-KFY 202605/20/26 10-QQ3 ended 12/31/2502/06/26 10-QQ2 ended 09/30/2511/10/25 10-QQ1 ended 06/30/2508/11/25

Disclosures

8-KCurrent report09/03/26 8-KCurrent report08/06/26 8-KCurrent report05/20/26 8-KCurrent report02/06/26 8-KCurrent report12/12/25

Prospectuses and Registrations

424B5Prospectus supplement12/12/25 FWPFree writing prospectus12/11/25 S-8Registration of securities for employees04/30/25 424B3Prospectus01/24/25 S-8Registration of securities for employees04/15/24

Proxies

DEF 14ADefinitive proxy07/22/26 DEFA14AAdditional proxy materials07/22/26 DEF 14ADefinitive proxy07/09/25 DEFA14AAdditional proxy materials07/09/25 DEF 14ADefinitive proxy06/26/24

Ownership

Form 4Insider transaction10/30/26 Form 4Insider transaction10/23/26 Form 4Insider transaction10/09/26 Form 4Insider transaction10/09/26 Form 4Insider transaction10/09/26

Other

ARSAnnual report to shareholders07/22/26 ARSAnnual report to shareholders07/09/25 DD01/21/25 ARSAnnual report to shareholders06/28/24 UPLOADLetter from the SEC02/28/24